Encompass Health EBIT 2010-2024 | EHC

Encompass Health annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Encompass Health EBIT for the quarter ending September 30, 2024 was $0.209B, a 16.56% increase year-over-year.
  • Encompass Health EBIT for the twelve months ending September 30, 2024 was $0.822B, a 14.1% increase year-over-year.
  • Encompass Health 2023 annual EBIT was $0.732B, a 16.38% increase from 2022.
  • Encompass Health 2022 annual EBIT was $0.629B, a 4.5% decline from 2021.
  • Encompass Health 2021 annual EBIT was $0.658B, a 25.34% increase from 2020.
Encompass Health Annual EBIT
(Millions of US $)
2023 $732
2022 $629
2021 $658
2020 $525
2019 $685
2018 $630
2017 $639
2016 $649
2015 $524
2014 $454
2013 $482
2012 $417
2011 $386
2010 $327
2009 $261
Encompass Health Quarterly EBIT
(Millions of US $)
2024-09-30 $209
2024-06-30 $216
2024-03-31 $208
2023-12-31 $190
2023-09-30 $179
2023-06-30 $184
2023-03-31 $179
2022-12-31 $179
2022-09-30 $148
2022-06-30 $150
2022-03-31 $152
2021-12-31 $66
2021-09-30 $167
2021-06-30 $218
2021-03-31 $208
2020-12-31 $73
2020-09-30 $173
2020-06-30 $99
2020-03-31 $180
2019-12-31 $155
2019-09-30 $172
2019-06-30 $171
2019-03-31 $188
2018-12-31 $111
2018-09-30 $173
2018-06-30 $177
2018-03-31 $169
2017-12-31 $158
2017-09-30 $162
2017-06-30 $156
2017-03-31 $163
2016-12-31 $162
2016-09-30 $162
2016-06-30 $164
2016-03-31 $161
2015-12-31 $130
2015-09-30 $136
2015-06-30 $138
2015-03-31 $121
2014-12-31 $97
2014-09-30 $114
2014-06-30 $128
2014-03-31 $116
2013-12-31 $119
2013-09-30 $131
2013-06-30 $112
2013-03-31 $120
2012-12-31 $105
2012-09-30 $104
2012-06-30 $103
2012-03-31 $105
2011-12-31 $98
2011-09-30 $90
2011-06-30 $100
2011-03-31 $99
2010-12-31 $84
2010-09-30 $75
2010-06-30 $79
2010-03-31 $88
2009-12-31 $62
2009-09-30 $67
2009-06-30 $39
2009-03-31 $94
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $10.405B $4.801B
Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.039B 12.12
Quest Diagnostics (DGX) United States $17.877B 18.12
DaVita (DVA) United States $12.667B 16.38
Chemed (CHE) United States $8.459B 26.00
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
U.S Physical Therapy (USPH) United States $1.428B 37.54
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
Psychemedics (PMD) United States $0.014B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00